OCCIDENT
Munich and Zug-based venture capital firm investing in deep tech start-ups spun out of scientific research across life sciences, industrial tech, and digital sectors.
OCCIDENT was founded in 2012, is headquartered in Munich, has 8 recorded investments, and includes 6 companies in its recorded portfolio.
- Headquarters
- Munich
- Founded
- 2012
- Website
- occident.group
- Portfolio Companies
- 6
- Total Investments
- 8
- Last Investment
- Jul 2026
- Geographic Focus
- Europe
Indexed holds 6 portfolio companies and 8 funding rounds for this investor. The full record is or through the API.
Investment Thesis
OCCIDENT is a Venture Capital firm based in Munich. It was founded in 2012. It has made 8 investments, including Algiax Pharmaceuticals, core sensing and Hemotune. Focus areas include Biotech.
Portfolio6
Co-investors24
Sign up to view co-investors
24 co-investors across 25 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×14 · Private Equity ×4 · Other ×2 · 16 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/occident"><img src="https://indexed.vc/api/badge/investor/occident" alt="OCCIDENT on Indexed.vc" width="260" height="76" /></a>